Lapaquistat clinical trials

Studies by the year they started

16 studies that test it; most in 2005 (9)

Who runs them

Industry 16 · Other 0

Takeda (16)

Often tested with

Tested in the same studies.

Atorvastatin (3) · Simvastatin (2) · Fenofibrate (1) · Serum Lipid Lowering Therapy (1) · Rosuvastatin (1) · Ezetimibe (1)

Studies

Open first, then newest update. How each study uses lapaquistat is read from its arms, and is right about nine times in ten.

Testing it · 16

• Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With HypercholesterolemiaTerminatedPhase 3TakedaNCT00532311Written as Lapaquistat acetate and stable statin therapy
• Safety of Lapaquistat Acetate in Subjects With HypercholesterolemiaCompletedPhase 3TakedaNCT00868127Written as Lapaquistat acetate
• Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary HypercholesterolemiaCompletedPhase 3TakedaNCT00143676Written as Lapaquistat acetate and atorvastatin
• Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary DyslipidemiaCompletedPhase 3TakedaNCT00487994Written as Lapaquistat acetate
• Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol LevelsCompletedPhase 2TakedaNCT00813527Written as Lapaquistat acetate and fenofibrate
• Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.CompletedPhase 3TakedaNCT00251680Written as Lapaquistat acetate and lipid-lowering therapy
• Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated CholesterolCompletedPhase 3TakedaNCT00143663Written as Lapaquistat Acetate
• Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With HypercholesterolemiaCompletedPhase 3TakedaNCT00249912Written as Lapaquistat acetate and rosuvastatin
• Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With HypercholesterolemiaCompletedPhase 3TakedaNCT00286481Written as Lapaquistat acetate and simvastatin
• Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With HypercholesterolemiaCompletedPhase 2TakedaNCT00864643Written as Lapaquistat acetate and atorvastatin
• Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.CompletedPhase 3TakedaNCT00256178Written as Lapaquistat acetate and simvastatin
• Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.CompletedPhase 3TakedaNCT00268697Written as Lapaquistat acetate
• Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With HypercholesterolemiaTerminatedPhase 3TakedaNCT00532558Written as Lapaquistat acetate
• Efficacy of Lapaquistat Acetate Co-Administered With Current Lipid-Lowering Treatment on Blood Cholesterol Levels in Subjects With Homozygous Familial HypercholesterolemiaTerminatedPhase 3TakedaNCT00263081Written as Lapaquistat acetate and current lipid-lowering treatment
• Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With HypercholesterolemiaTerminatedPhase 3TakedaNCT00249899Written as Lapaquistat acetate and stable statin therapy
• Efficacy of Lapaquistat Acetate in Subjects With HypercholesterolemiaTerminatedPhase 2TakedaNCT00865228Written as Lapaquistat acetate

Codes

What other systems call lapaquistat · ClinicalTrials.gg INT004481

• UNII (FDA) PEZ79BV72XLAPAQUISTATConfirmed FDA, Wikidata
• Wikidata Q6488102lapaquistatConfirmed FDA, Wikidata
• NCI Thesaurus C96287LapaquistatOne source FDA
• DrugBank DB16215One source Wikidata

Also registered as lapaquistat acetate (UNII IUH3AY74O3).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.